Department of Clinical Medicine, University of Copenhagen, Copenhagen, Denmark.
Department of Oto-Rhino-Laryngology, Nordsjaellands Hospital, Hillerod, Denmark.
Int J Audiol. 2020 Sep;59(9):647-653. doi: 10.1080/14992027.2020.1727967. Epub 2020 Feb 26.
Systematic evaluation of studies using otoacoustic emissions (OAEs) to monitor cochlear damage in patients with bacterial meningitis. Systematic review. This includes articles retrieved from PUBMED and EMBASE. The search-strategy was based on the PICO-model. Data processing involved Cochrane Public Health Data Extraction template in addition to assessment of risk of bias and applicability with the Second Quality Assessment of Diagnostic Accuracy Studies (QUADAS-2) tool. Thirty-eight articles were identified with 6 studies comprising 391 children and 17 adult patients eligible for full assessment. Studies were heterogenic and the timing of OAE was incomparable between studies. The frequency of severe loss of hearing was reported to occur between 1.6 and 21% of the patients with culture-proven meningitis. The included studies, albeit heterogenic, found OAE-screening feasible and sensitive in children recovering from bacterial meningitis. No children with hearing loss were reported to pass an OAE screening in any of the included studies. The timing, sensitivity and extent of sensorineural hearing loss determined by OAE could not be assessed from the included studies. Levels of risk of bias were inconsistent and the clinical feasibility for routine inclusion of patients with bacterial meningitis was uncertain. The technological development within this field implies the need for further research.
应用耳声发射(OAE)监测细菌性脑膜炎患者耳蜗损伤的研究的系统评价。系统综述。这包括从 PUBMED 和 EMBASE 检索到的文章。搜索策略基于 PICO 模型。数据处理除了使用第二版诊断准确性研究的质量评估工具(QUADAS-2)评估偏倚风险和适用性外,还涉及 Cochrane 公共卫生数据提取模板。确定了 38 篇文章,其中 6 项研究包括 391 名儿童和 17 名成人患者,符合全面评估的条件。研究具有异质性,并且研究之间的 OAE 时间不可比。报告称,在培养证实的脑膜炎患者中,严重听力损失的发生率为 1.6%至 21%。尽管存在异质性,但纳入的研究发现 OAE 筛查在细菌性脑膜炎康复的儿童中是可行且敏感的。在纳入的任何研究中,都没有报告有听力损失的儿童通过了 OAE 筛查。无法从纳入的研究中评估 OAE 确定的感音神经性听力损失的时间、敏感性和程度。偏倚风险水平不一致,细菌性脑膜炎患者常规纳入的临床可行性尚不确定。该领域的技术发展意味着需要进一步研究。